Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Science and Society
  • Published:

From diversity to delivery: the case of the Indian Genome Variation initiative

Abstract

India currently has the world's second-largest population along with a fast-growing economy and significant economic disparity. It also continues to experience a high rate of infectious disease and increasingly higher rates of chronic diseases. However, India cannot afford to import expensive technologies and therapeutics nor can it, as an emerging economy, emulate the health-delivery systems of the developed world. Instead, to address these challenges it is looking to biotechnology-based innovation in the field of genomics. The Indian Genome Variation (IGV) consortium, a government-funded collaborative network among seven local institutions, is a reflection of these efforts. The IGV has recently developed the first large-scale database of genomic diversity in the Indian population that will facilitate research on disease predisposition, adverse drug reactions and population migration.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Boutayeb, A. The double burden of communicable and non-communicable diseases in developing countries. Trans. R. Soc. Trop. Med. Hyg. 100, 191–199 (2006).

    Article  Google Scholar 

  2. Indian Genome Variation Consortium. Genetic landscape of the people of India: a canvas for disease gene exploration. J. Genet. 87, 3–20 (2008).

  3. Indian Genome Variation Consortium. The Indian Genome Variation database (IGVdb): a project overview. Hum. Genet. 118, 1–11 (2005).

  4. Séguin, B. & Hardy, B, Singer, P. A. & Daar, A. S. Genomic medicine and developing countries: creating a room of their own. Nature Rev. Genet. 9, 487–493 (2008).

    Article  Google Scholar 

  5. Séguin, B., Hardy, B., Singer, P. A. & Daar, A. S. Human genomic variation initiatives in emerging economies and developing countries. Nature Rev. Genet. 9 (Suppl), S3–S4 (2008).

    Article  Google Scholar 

  6. Nundy, S. & Gulhati, C. M. A new colonialism? — Conducting clinical trials in India. N. Engl. J. Med. 352, 1633–1636 (2005).

    Article  CAS  Google Scholar 

  7. Maiti, R. & M, R. Clinical trials in India. Pharmacol. Res. 56, 1–10 (2007).

    Article  Google Scholar 

  8. Singh, S. India Bullish on Global Clinical Trial Business Opportunity. Science and Marketplace [online], (2006).

  9. Thiers, F., Sinskey, A. & Berndt, E. Trends in the globalization of clinical trials. Nature Rev. Drug Discov. 7, 13–14 (2008).

    Article  CAS  Google Scholar 

  10. Frew, S. E. et al. India's health biotech sector at a crossroads. Nature Biotechnol. 25, 403–417 (2007).

    Article  CAS  Google Scholar 

  11. Patwardhan, B. Ayugenomics: integration for customized medicine. Indian J. Nat. Products 19, 16–23 (2003).

    Google Scholar 

  12. Patwardhan, B., Vaidya, A. & Chorghade, M. Ayurveda and natural product drug discovery. Current Sci. 86, 789–799 (2004).

    Google Scholar 

  13. Indo-Asian News Service. Indian biotech sector crosses $2 billion in FY 2007. Twocircles.net [online], (2007).

  14. Jayaraman, K. S. Database targets Parsi genes. Nature 446, 475 (2007).

    Article  CAS  Google Scholar 

  15. Becerril, A. Aprueba el Senado sanciones a quienes trasladen tejido humano fuera de México. La Journada [online], (2008) (in Spanish).

  16. Prathapan, K. et al. Death sentence on taxonomy in India. Curr. Sci. 94, 170–171 (2008).

    Google Scholar 

  17. Mudur, G. India invests heavily in genomics research. BMJ 322, 576 (2001).

    Article  CAS  Google Scholar 

  18. Stein, L. Congress Passes Bill Barring Genetic Discrimination. Scientific American [online], (2008).

    Google Scholar 

  19. Kukreti, R. et al. Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics. Pharmacogenomics 6, 399–410 (2005).

    Article  CAS  Google Scholar 

  20. Bhatnagar, P., Guleria, R. & Kukreti, R. Variable therapeutic response in asthma: a genetic perspective. Personalized Medicine 3, 61–78 (2006).

    Article  CAS  Google Scholar 

  21. Séguin, B., Hardy, B., Singer, P. A. & Daar, A. S. Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN). Nature Rev. Genet. 9 (Suppl), S5–S9 (2008).

    Article  Google Scholar 

  22. Thorsteinsdottir, H., Quach, U., Daar, A. S. & Singer, P. A. Conclusions: promoting biotechnology innovation in developing countries. Nature Biotechnol. 22 (Suppl), DC48–DC52 (2004).

    Article  CAS  Google Scholar 

  23. Frew, S. E., Sammut, S. M., Siu, W. W., Daar, A. S. & Singer, P. A. The role of the domestic private sector in developing countries for addressing local health needs. Int. J. Biotechnology 8, 91–102 (2006).

    Article  Google Scholar 

  24. Holm, S. in The Power of Pills: Social, Ethical and Legal Issues in Drug Development, Marketing and Pricing (eds Cohen, J. C., Illingworth, P. & Schuklenk, U.) 98–109 (Pluto Press, Ann Arbor, Michigan, 2006).

    Google Scholar 

  25. Prahalad, C. K. & Hart, S. L. The Fortune at the Bottom of the Pyramid. Strategy and Business Magazine. [online], (2002).

    Google Scholar 

  26. Hardy, B., Séguin, B., Ramesar, R., Singer, P. A. & Daar, A. S. South Africa: from species cradle to genomic applications. Nature Rev. Genet. 9 (Suppl), S19–S23 (2008).

    Article  Google Scholar 

  27. Séguin, B., Hardy, B., Singer, P. A. & Daar, A. S. Universal health care, genomic medicine and Thailand: Investing in today and tomorrow. Nature Rev. Genet. 9 (Suppl), S14–S19 (2008).

    Article  Google Scholar 

Download references

Acknowledgements

This project was funded by Genome Canada through the Ontario Genomics Institute. The Indian Council of Medical Research provided in kind co-funding for this research. The McLaughlin–Rotman Centre for Global Health, Program on Life Sciences, Ethics and Policy is primarily supported by Genome Canada through the Ontario Genomics Institute, the Ontario Research Fund, and the Bill and Melinda Gates Foundation. Other matching partners are listed atThe McLaughlin–Rotman Centre for Global Health web site. A.S.D. and P.A.S. are supported by the McLaughlin Centre for Molecular Medicine. P.A.S. is supported by a Canadian Institutes of Health Research Distinguished Investigator award. The IGV project was supported by SCIR, India.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abdallah S. Daar.

Related links

Related links

FURTHER INFORMATION

McLaughlin–Rotman Centre for Global Health

Africa Genome Education Institute

Census of India Rural–Urban Distribution

Ethical Guidelines for Biomedical Research on Human Participants

Genetics India

Guidelines for Exchange of Human Biological Material for Biomedical Research Purposes

Human Genetics and Genome Analysis

India Country Overview 2007, World Bank web site

National Biotechnology Development Strategy

National Institute of Genomic Medicine (INMEGEN), Mexico

New Millennium Indian Technology Leadership Initiative

Thailand Center for Excellence in Life Sciences

The Human Genome

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hardy, BJ., Séguin, B., Singer, P. et al. From diversity to delivery: the case of the Indian Genome Variation initiative. Nat Rev Genet 9 (Suppl 1), S9–S14 (2008). https://doi.org/10.1038/nrg2440

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrg2440

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing